These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 108706)

  • 41. Hippocampal cell nuclear binding of corticosterone following 5,7-dihydroxytryptamine.
    Siegel RA; Weidenfeld J; Chen M; Feldman S; Melamed E; Chowers I
    Mol Cell Endocrinol; 1983 Aug; 31(2-3):253-9. PubMed ID: 6195032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.
    Fischette CT; Nock B; Renner K
    Brain Res; 1987 Sep; 421(1-2):263-79. PubMed ID: 3690273
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
    Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine.
    Stachowiak MK; Stricker EM; Jacoby JH; Zigmond MJ
    Biochem Pharmacol; 1986 Apr; 35(8):1241-8. PubMed ID: 2421731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological evidence of supersensitivity of central serotonergic receptors involved in the control of prolactin secretion.
    Quattrone A; Schettini G; Annunziato L; Di Renzo G
    Eur J Pharmacol; 1981 Nov; 76(1):9-13. PubMed ID: 7318925
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of neonatal administration of 5,7-dihydroxytryptamine on locomotor activity.
    Lucot JB; Seiden LS
    Psychopharmacology (Berl); 1982; 77(2):114-6. PubMed ID: 6812128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serotonin and human myoclonus. Rationale for the use of serotonin receptor agonists and antagonists.
    Pranzatelli MR
    Arch Neurol; 1994 Jun; 51(6):605-17. PubMed ID: 7515228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of body weight changes after selective serotonin depletion with 5,7-dihydroxytryptamine.
    Baez LA; Browning RA; Cusatis M
    Prog Neuropsychopharmacol; 1980; 4(2):123-7. PubMed ID: 7403347
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of depletion of brain 5-hydroxytryptamine by 5,7-dihydroxytryptamine on ethanol tolerance and dependence in the rat.
    Wood JM
    Psychopharmacology (Berl); 1980 Jan; 67(1):67-72. PubMed ID: 6768080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serotonin depletion modifies the pigeon electroretinogram.
    Porciatti V; Alesci R; Bagnoli P; Signorini G; Raffaelli A
    Doc Ophthalmol; 1989 May; 72(1):93-100. PubMed ID: 2478351
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of intracerebroventricular 5,7-dihydroxytryptamine on morphine analgesia is time-dependent.
    Romandini S; Pich EM; Esposito E; Kruszewska AZ; Samanin R
    Life Sci; 1986 Mar; 38(10):869-75. PubMed ID: 3951313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term effects of 5,7-dihydroxytryptamine administered at birth on the development of brain monoamines.
    Lytle LD; Jacoby JH; Nelson MF; Baumgarten HG
    Life Sci; 1974 Sep; 15(6):1203-17. PubMed ID: 4549961
    [No Abstract]   [Full Text] [Related]  

  • 53. Unilateral 5,7-dihydroxytryptamine lesions of the dorsal raphe nucleus (DRN) and rat rotational behaviour.
    Blackburn TP; Foster GA; Heapy CG; Kemp JD
    Eur J Pharmacol; 1980 Oct; 67(4):427-38. PubMed ID: 7449825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serotonin depletion by 5,7-dihydroxytryptamine or para-chloroamphetamine does not affect cancer anorexia.
    Chance WT; von Meyenfeldt M; Fischer JE
    Pharmacol Biochem Behav; 1983 Jan; 18(1):115-21. PubMed ID: 6187026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
    Lorens SA; Hata N; Cabrera T; Hamilton ME
    NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039
    [No Abstract]   [Full Text] [Related]  

  • 56. Evaluation of the cytotoxicity of dihydroxytryptamines and 5-hydroxytryptamine antagonists as cytotoxic agents in dimethylhydrazine-induced adenocarcinomata.
    Tutton PJ; Barkla DH
    Cancer Chemother Pharmacol; 1978; 1(4):209-13. PubMed ID: 35286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Developmental changes in serotonin and 5-hydroxyindoleacetic acid concentrations and opiate receptor binding in rat spinal cord following neonatal 5,7-dihydroxytryptamine treatment.
    Kirby ML; Mattio TG
    Dev Neurosci; 1982; 5(5-6):394-402. PubMed ID: 6186451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distribution of the radioactivity in the central nervous system of the developing rat following intracisternal or subcutaneous administration of 14C-5,7-dihydroxytryptamine.
    Sievers J; Baumgarten HG; Klemm HP; Schlossberger HG; Lolova I
    Bibl Anat; 1981; (19):302-7. PubMed ID: 7225075
    [No Abstract]   [Full Text] [Related]  

  • 59. Regulation of [3H]imipramine binding sites in rat brain regions: effect of neonatal 5,7-dihydroxytryptamine treatment.
    Hrdina PD; Pappas BA; Bialik RJ; Ryan CL
    Eur J Pharmacol; 1982 Sep; 83(3-4):343-4. PubMed ID: 7173315
    [No Abstract]   [Full Text] [Related]  

  • 60. Motor habituation in the DHT model: bin analysis of daytime and nocturnal locomotor activity.
    Pranzatelli MR; Snodgrass SR
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1679-86. PubMed ID: 3488554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.